Caspase activation precedes and leads to tangles

Nature

Volumn 464, Issue 7292, 2010, Pages 1201-1204

  De Calignon, Alix ^a,b   Fox, Leora M ^a   Pitstick, Rose ^c   Carlson, George A ^c   Bacskai, Brian J ^a   Spires Jones, Tara L ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SORBONNE UNIVERSITÉ   (France)

^c McLaughlin Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 7;

APOPTOSIS; CYTOLOGY; NEUROLOGY; PROTEIN; RODENT; TOXIC SUBSTANCE; VIRUS; WILD POPULATION;

ALZHEIMER DISEASE; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VIVO STUDY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING;

ANIMALS; BRAIN; CASPASES; CELL DEATH; ENZYME ACTIVATION; HUMANS; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; NEURONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOLUBILITY; TAU PROTEINS; TIME FACTORS;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MUS; MUS MUSCULUS;

EID: 77951540816     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08890     Document Type: Article

References (30)

1. Ramsden, M. et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25, 10637-10647 (2005).
2. Gómez-Isla, T. et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24 (1997).
3. Augustinack, J. C., Schneider, A., Mandelkow, E. M. & Hyman, B. T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35 (2002).
4. Ramalho, R. M. et al. Apoptosis in transgenic mice expressing the P301L mutated form of human tau. Mol. Med. 14, 309-317 (2008).
5. Guo, H. et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165, 523-531 (2004).
6. Rohn, T. T. et al. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am. J. Pathol. 158, 189-198 (2001).
7. Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481 (2005).
8. Spires, T. L. et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168, 1598-1607 (2006).
9. Spires-Jones, T. L. et al. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci. 28, 862-867 (2008).
10. de Calignon, A., Spires-Jones, T. L., Pitstick, R., Carlson, G. A. & Hyman, B. T. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. J. Neuropathol. Exp. Neurol. 68, 757-761 (2009).
11. Styren, S. D., Hamilton, R. L., Styren, G. C. & Klunk, W. E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem. 48, 1223-1232 (2000).
12. Velasco, A. et al. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3- hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS Lett. 582, 901-906 (2008).
13. Rissman, R. A. et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130 (2004).
14. Zhang, Q., Zhang, X. & Sun, A. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Acta Neuropathol. 117, 687-697 (2009).
15. Basurto-Islas, G. et al. Accumulation of aspartic acid421-and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67, 470-483 (2008).
16. Guillozet-Bongaarts, A. L. et al. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol. Aging 26, 1015-1022 (2005).
17. Delobel, P. et al. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am. J. Pathol. 172, 123-131 (2008).
18. Horowitz, P. M. et al. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902 (2004).
19. Guillozet-Bongaarts, A. L. et al. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97, 1005-1014 (2006).
20. Jaworski, T. et al. AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice. PLoS One 4, e7280 (2009).
21. Andorfer, C. et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590 (2003).
22. Gamblin, T. C. et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl Acad. Sci. USA 100, 10032-10037 (2003).
23. Yin, H. & Kuret, J. C-terminal truncation modulates both nucleation and extension phases of tau fibrillization. FEBS Lett. 580, 211-215 (2006).
24. Ding, H., Matthews, T. A. & Johnson, G. V. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. J. Biol. Chem. 281, 19107-19114 (2006).
25. Mocanu, M. M. et al. The potential for b-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748 (2008).
26. Wang, Y. et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 18, 4153-4170 (2009).
27. Park, S. Y., Tournell, C., Sinjoanu, R. C. & Ferreira, A. Caspase-3-and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in b-amyloid-treated hippocampal neurons. Neuroscience 144, 119-127 (2007).
28. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547-5551 (1992).
29. Mayford, M. et al. Control of memory formation through regulated expression of a CaMKII transgene. Science 274, 1678-1683 (1996).
30. Skoch, J., Hickey, G. A., Kajdasz, S. T., Hyman, B. T. & Bacskai, B. J. in Amyloid proteins: methods and protocols (ed. Sigurdsson, E. M.) 349-364 (Humana Press, 2004)